Meta-analyses involving cross-over trials: Methodological issues

International Journal of Epidemiology

Volumn 31, Issue 1, 2002, Pages 140-149

  Elbourne, Diana R ^a   Altman, Douglas G ^b   Higgins, Julian P T ^c   Curtin, Francois ^a   Worthington, Helen V ^d   Vail, Andy ^e  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY DENTAL HOSPITAL OF MANCHESTER   (United Kingdom)

^e HOPE HOSPITAL   (United Kingdom)

Author keywords

Cross over trials; Meta analysis

Indexed keywords

DIHYDROCODEINE; INSULIN; INSULIN LISPRO; OPIATE; PLACEBO;

DESIGN; EPIDEMIOLOGY; META-ANALYSIS; METHODOLOGY;

ARTICLE; CALCULATION; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DYSPNEA; HUMAN; HYPOGLYCEMIA; INFORMATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; META ANALYSIS; METHODOLOGY; MULTICENTER STUDY; PALLIATIVE THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; TERMINAL DISEASE; TREATMENT OUTCOME;

EID: 0036211922     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/31.1.140     Document Type: Article

References (33)

1. Patients' preference in indomethacin trials: An overview
2. Cross-over trials in Clinical Research
3. Design and Analysis of Cross-over Trials
4. A review of randomised controlled trials published in Archives of Disease in Childhood from 1982-96
5. Content and quality of 2000 controlled trials in schizophrenia over 50 years
6. The two-period change over design and its use in clinical trials
7. The performance of the two-stage analysis of two-treatment, two-period cross-over trials
8. The two-period cross-over clinical trial
9. Crossover or parallel design in infertility trials? The discussion continues
10. Differences between crossover and parallel study designs-debate?
11. Dihydrocodeine for breathlessness in 'pink pullers'
12. Variance imputation for overviews of clinical trials with continuous response
13. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment
14. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with Type I diabetes
15. Proportions and their differences
16. Epidemiological studies
17. Meta-analysis combining parallel and cross-over clinical trials: II. Binary outcomes
18. Marginal modelling of binary cross-over data
19. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis
20. Meta-analysis combining parallel and cross-over clinical trials: I. Continuous outcomes
21. Meta-analysis combining parallel and cross-over clinical trials: III. The issue of carry-over
22. Validation of a meta-analysis: The effects of fish oil in rheumatoid arthritis
23. Opioids for the palliation of breathlessness in terminal illness (Cochrane review)
24. The statistical basis of meta-analysis
25. The Cochrane Library Issue I
26. Prophylactic antibiotics for cystic fibrosis
27. Dehydroepiandrosterone (DHEA) supplementation for cognition and well-being
28. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials
29. Outcome measures in split mouth caries trials and their statistical evaluation
30. People and eyes: Statistical approaches in ophthalmology
31. Guided tissue regeneration for periodontal infra-bony defects
32. Statistical methods for the meta-analysis of cluster randomization trials
33. Meta-analysis of qualitative and quantitative evidence: An example based on studies of patient satisfaction